Skip to content
Start your journey

After lymphoma treatment

Why follow-up relies more on symptoms than scans, the late effects that matter after chest radiotherapy and intensive chemotherapy, and the vaccinations and monitoring to ask about.

4 min read · Part of Cancer Types

Written by The LifeAfterward editorial team from the sources listed at the end of this page.

Not individually reviewed by a clinician. This page is written from published clinical guidance, listed in full at the end, and is general information rather than medical advice — your own team knows your case. See our editorial standards.

Last checked against its sources · Last updated · Next check due

In short

  • Routine scanning after successful treatment is used sparingly — most relapses are picked up because of symptoms.
  • Late effects matter more in lymphoma than in many cancers, because treatment is often given at a young age and cure rates are high.
  • People treated with chest radiotherapy, particularly when young, may need additional long-term screening — ask specifically.
  • Thyroid function, heart health, fertility and infection risk are the recurring themes of long-term follow-up.

What this means

Lymphoma is one of the cancers where survivorship care is most consequential, because many people are treated in their twenties and thirties and live for decades afterwards. The important conversation is not about scan frequency; it is about which long-term monitoring applies to the specific treatment you had.

Follow-up

  • Clinical review with examination of lymph node areas, initially every few months.
  • Blood tests, including full blood count and often ESR or LDH depending on the type.
  • Imaging used selectively — routine surveillance scanning of people in remission without symptoms is limited in many protocols, because it has not been shown to improve outcomes and produces false alarms.
  • A clear route back for symptoms between appointments, which is the main safety net.

Symptoms worth reporting include new or enlarging lymph nodes, drenching night sweats, unexplained fever, unexplained weight loss, and persistent itching — the same "B symptoms" that often lead to diagnosis.

Long-term effects to ask about

  • Thyroid: underactivity is common after neck or chest radiotherapy. Annual thyroid function testing is usually recommended.
  • Heart: anthracyclines and chest radiotherapy can affect heart muscle, valves and coronary arteries years later. Ask about monitoring and about managing blood pressure and cholesterol actively.
  • Lungs: bleomycin and chest radiotherapy can affect lung function. Report persistent breathlessness or cough.
  • Second cancers: risk is increased after some regimens and after radiotherapy. In particular, people who had chest radiotherapy at a young age may be advised to start breast screening earlier and with additional imaging — ask specifically whether this applies to you.
  • Fertility and hormones: varies by regimen; ask about assessment and, where relevant, testosterone or menopause management.
  • Infection risk: particularly after stem cell transplant, or if your spleen was removed or irradiated. This may mean specific vaccinations and, sometimes, preventive antibiotics.
  • Fatigue: common and often prolonged after intensive treatment.

Vaccination and infection

  • Ask when your immune system is expected to recover and when vaccines are effective again.
  • After a stem cell transplant, the childhood vaccination schedule is usually repeated on a specific timetable.
  • Some live vaccines must be avoided for a period — always check before travel vaccinations.
  • If you have no functioning spleen, you need specific vaccinations, an emergency plan for fever, and often standby antibiotics. Carry documentation.

What to ask your healthcare team

  • What is my follow-up plan, and how are relapses usually detected in my type of lymphoma?
  • Given my exact regimen and radiotherapy field, which late effects apply to me?
  • Do I need annual thyroid tests, heart monitoring or additional screening?
  • Was my chest irradiated, and does that change my breast screening recommendations?
  • What vaccinations do I need, and when?
  • Do I have a functioning spleen, and if not, what is my infection plan?

Save questions to My Journey so you have them in the room, or use a ready-made list.

When to seek medical advice

Contact your healthcare team if you have:

  • New or growing lymph nodes anywhere.
  • Drenching night sweats, unexplained fever, or unexplained weight loss.
  • Persistent itching without a rash.
  • Persistent breathlessness or cough.
  • Persistent fatigue, weight change or cold intolerance — possible thyroid problems.

Get emergency help the same day if you have:

  • Fever or feeling suddenly very unwell if you are immunosuppressed or have no functioning spleen — this can progress to sepsis quickly and needs emergency treatment.
  • Severe breathlessness or chest pain.

If you are worried and unsure, contact your team anyway — they would far rather hear from you unnecessarily than late. What to do in an emergency.

Common questions

Why am I not having regular scans after lymphoma treatment?

For many lymphomas, routine surveillance scanning of people in remission without symptoms has not been shown to improve outcomes, and it produces false alarms and repeated radiation exposure. Follow-up therefore relies on examination, blood tests and prompt reporting of symptoms, with a fast route back into the clinic.

Do I need extra screening after chest radiotherapy for Hodgkin lymphoma?

Possibly. People treated with chest radiotherapy at a young age have an increased long-term risk of breast cancer and heart disease, and additional or earlier screening is often recommended. Ask your team specifically what your radiotherapy field was and what monitoring applies.

Sources

This page was written from the guidance below and checked against it on . Links are re-checked at each review — see our editorial standards.

  1. ASCO (Cancer.Net). Survivorship
  2. National Comprehensive Cancer Network. NCCN Guidelines for Patients
  3. National Cancer Institute (US). Late effects of cancer treatment
  4. European Society of Cardiology (2022). Guidelines on cardio-oncology
  5. National Cancer Institute (US). Follow-up medical care after cancer treatment